Objective:

To explore emerging technologies and treatment strategies for effective glaucoma management.

Approach:

Key Findings:

• 10-2 visual field testing can identify central defects missed by traditional testing.
• SLT can lead to long-term medication-free periods and lower progression rates.
• Normal-tension glaucoma may progress despite controlled IOP; systemic factors should be evaluated.
• Nocturnal IOP fluctuations can impact disease progression.
• Emerging drug-delivery technologies may enhance medication adherence.
• MIGS can improve patient quality of life and reduce medication side effects.

Interpretation:

Successful glaucoma management requires a comprehensive approach that includes IOP reduction, structural and functional testing, and consideration of patient-specific factors.

Conclusion:

A multifaceted strategy is essential for effective glaucoma management, integrating new technologies and individualized patient care.

Attribution Notice

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.